Prevalence and incidence of endocrine disorders in children: Results of a survey in Baden-Wuerttemberg and Bavaria (EndoPrIn BB) 20002001

Klinische Padiatrie

Volumn 222, Issue 2, 2010, Pages 67-72

  Schweizer, Roland ^a   Blumenstock, G ^a   Mangelsdorf, K ^a   Ehehalt, S ^a   Rossner L ^a   Dorn, T ^a   Binder, G ^a   Ranke, M B ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Children; Endocrine disorders; Incidence; Prevalence

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; CONGENITAL ADRENAL HYPERPLASIA; ENDOCRINE DISEASE; FEMALE; GERMANY; GRAVES DISEASE; GROWTH DISORDER; GROWTH HORMONE DEFICIENCY; HEALTH SURVEY; HUMAN; HYPOTHYROIDISM; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; NEWBORN; PEDIATRICIAN; PEDIATRICS; PRECOCIOUS PUBERTY; PRESCHOOL CHILD; PREVALENCE; PRIMARY CONGENITAL HYPOTHYREOSIS; SCHOOL CHILD; TURNER SYNDROME;

ADOLESCENT; ADRENOGENITAL SYNDROME; CHILD; CHILD, PRESCHOOL; CONGENITAL HYPOTHYROIDISM; CROSS-SECTIONAL STUDIES; DWARFISM, PITUITARY; ENDOCRINE SYSTEM DISEASES; FEMALE; GERMANY; GRAVES DISEASE; HEALTH SURVEYS; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; PUBERTY, PRECOCIOUS; TURNER SYNDROME;

EID: 77949890574     PISSN: 03008630     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0029-1241868     Document Type: Article

References (39)

1. Adeyokunnu AA. The incidence of Turner's syndrome in Ibadan, Nigeria. Afr J Med Med Sci 1982 11 105-112
2. Altman DE, etal. Statistics with confidence: Confidence intervals and statistical guidelines. 2 ed. BMJ Books, London 2000
3. Ashizawa K. Epidemiology of Basedow disease and other thyroid diseases. Nippon Rinsho 2006 64 2194-2200
4. Audi L, etal. Long-term GH therapy: epidemiology and auxologic outcome. Horm Res 2002 57 113-119
5. Bettendorf M. Thyroid disorders in children from birth to adolescence. Eur J Nucl Med Mol Imaging 2002 29 S439-446
6. Bölling T. Pediatric radiation oncology in Germany a study of availability and application. Klin Padiatr 2008 220 179-182
7. Cesario SK, etal. Precocious puberty: a comprehensive review of literature. J Obstet Gynecol Neonatal Nurs 2007 36 263-274
8. Ehehalt S, etal. Continuous rise in incidence of childhood type 1 diabetes in Germany. Diabet Med 2008 25 755-757
9. GH Research Society. Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: Summary statement of the GH Research Society. J Clin Endocrinol Metabol 2000 85 3990-3993
10. Gonzalez ER. For puberty that comes too soon, new treatment highly effective. JAMA 1982 248 1149-1151
11. Gravholt CH, etal. Prenatal and postnatal prevalence of Turner's syndrome: A registry study. BMJ 1996 312 16-21
12. Green A, etal. Incidence of childhood-onset insulin-dependent diabetes mellitus: The EURODIAB ACE study. Lancet 1992 339 905-909
13. Höpfner S, etal. Neugeborenenhypothyreosescreening in Deutschland. Retrospektive Analyse der Entwicklung von betroffenen Kindern am Beispiel des Bundeslandes Hessen. Klin Padiatr 2007 219 206-211
14. Kalk WJ, etal. Incidence and causes of hyperthyroidism in blacks. S Afr Med J 1989 75 114-117
15. Kaplowitz P. Clinical characteristics of 104 children referred for evaluation of precocious puberty. J Clin Endocrinol Metab 2004 89 3644-3650
16. Konrady A. Incidence of the most frequently occurring diseases causing hyperthyroidism syndrome. Orv Hetil 1989 130 1967-1971
17. Kumorowicz-Kopiec M, etal. Incidence of Grave's disease in children in some regions of south-eastern Poland. Przegl Lek 2004 61 872-875
18. LaPorte RE, etal. Counting diabetes in the next millennium. Application of capture-recapture technology. Diabetes Care 1993 16 528-534
19. LaPorte RE, etal. Counting birds, bees, and NCDs. Lancet 1992 339 494-495
20. Lentner C. Exact 95% confidence limits, poisson distribution. Ciba-Geigy, Basel 1982
21. Lindsay R, etal. Utah Growth Study: Growth standards and the prevalence of growth hormone deficiency. J Pediatr 1994 125 29-35
22. Massart F, etal. High incidence of central precocious puberty in a bounded geographic area of northwest Tuscany: An estrogen disrupter epidemic? Gynecol Endocrinol 2005 20 92-98
23. Midyett LK, etal. Are pubertal changes in girls before age 8 benign? Pediatrics 2003 111 47-51
24. Migliaretti G, etal. Incidence and prevalence rate estimation of GH treatment exposure in Piedmont pediatric population in the years 20022004: Data from the GH Registry. J Endocrinol Invest 2006 29 438-442
25. Neu A et, al. Rising incidence of type 1 diabetes in germany: 12-year trend analysis in children 014 years of age. Diabetes Care 2001 24 785-786
26. Neu A, etal. Varying clinical presentations at onset of type 1 diabetes mellitus in children-epidemiological evidence for different subtypes of the disease? Pediatric Diabetes 2001 2 147-153
27. Pang SY, etal. Worldwide experience in newborn screening for classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Pediatrics 1988 81 866-874
28. Ranke MB, etal. Major determinants of height development in turner syndrome (TS) patients treated with GH: analysis of 987 patients from KIGS. Pediat Res 2007 61 105-110
29. Roberts HE, etal. Population study of congenital hypothyroidism and associated birth defects, Atlanta, 19791992. Am J Med Genet 1997 71 29-32
30. Skordis N, etal. High prevalence of congenital hypothyroidism in the Greek Cypriot population: Results of the neonatal screening program 19902000. J Pediatr Endocrinol Metab 2005 18 453-461
31. Stochholm K, etal. Incidence of GH deficiency, a nationwide study. Eur J Endocrinol 2006 155 61-71
32. Stochholm K, etal. Prevalence, incidence, diagnostic delay, and mortality in Turner syndrome. J Clin Endocrinol Metab 2006 91 3897-3902
33. Teilmann G, etal. Increased risk of precocious puberty in internationally adopted children in Denmark. Pediatrics 2006 118 e391-e399
34. Toublanc JE. Comparison of epidemiological data on congenital hypothyroidism in Europe with those of other parts in the world. Horm Res 1992 38 230-235
35. Van der Kamp HJ, etal. Newborn screening for congenital adrenal hyperplasia in the Netherlands. Pediatrics 2001 108 1320-1324
36. Vimpani GV, etal. Prevalence of severe growth hormone deficiency. Br Med J 1977 2 427-430
37. Votava F, etal. Estimation of the false-negative rate in newborn screening for congenital adrenal hyperplasia. Eur Endocrinol 2005 152 869-874
38. Werder EA, etal. The incidence of congenital adrenal hyperplasia in Switzerland- a survey of patients born in 1960 to 1974. Helv Paediatr Acta 1980 35 5-11
39. Wilson EB. Probable inference, the law of succession, and statistical inference. J Am Stat Assoc 1927 22 209-212 211